Publications by authors named "P Aftimos"

Claim this Profile
E
Economic Evaluation of Comprehensive Genomic Profiling in an Advanced Solid Cancer Population.
Lucas F van Schaik, Brigitte Maes, Pieter-Jan Volders, Guy Froyen, Philippe Aftimos

JAMA Netw Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer: Updated Efficacy Results from the phase 3 EMBER-3 trial.
K L Jhaveri, P Neven, M L Casalnuovo, S-B Kim, E Tokunaga, P Aftimos

Ann Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imlunestrant, an oral selective estrogen receptor degrader, in combination with HER2 directed therapy, with or without abemaciclib, in ER-positive, HER2-positive advanced breast cancer: results from the phase 1a/1b EMBER study.
Manali Bhave, Komal L Jhaveri, Peter A Kaufman, Philippe Aftimos, Janine Lombard

Breast Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and clinical analyses of gene fusions identify therapeutic targets in paired primary and metastatic breast cancer from the AURORA program (BIG 14-01).
Chiara Biagioni, Danai Fimereli, Alexandre Irrthum, Angel Guerrero-Zotano, Martine Piccart, Philippe Aftimos

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete remission with olaparib in BRIP1-mutated metastatic high-grade pleomorphic sarcoma: case study and literature review - an example of a genomic profiling-based tumor treatment, in a cancer type with high unmet clinical need.
Alexander D J Thooft, Sofie Joris, Celine Jacobs, David Creytens, Sylvie Rottey, Philippe Aftimos

Acta Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis